From Casetext: Smarter Legal Research

People v. Morales

Appellate Division of the Supreme Court of New York, Second Department
May 28, 1996
227 A.D.2d 648 (N.Y. App. Div. 1996)

Summary

holding that PCR method had gained general acceptance under Frye

Summary of this case from People v. Shreck

Opinion

May 28, 1996

Appeal from the County Court, Rockland County (Kelly, J.).


Ordered that the judgment is affirmed.

The defendant shot two men, killing one of them, in a drug-related dispute. Contrary to the defendant's contention, the People proved by clear and convincing evidence that the complainant had an independent source to identify the defendant in court. The complainant testified that before unlocking the front door of his apartment, he looked out the window and, in the porch light, saw the defendant and a man known to him as "G". The complainant recognized the defendant because he had been to the apartment just one month before with "G". When the door burst open, the complainant, with an unobstructed view, saw the defendant fire a gun at him. Thus, the complainant not only had a sufficient opportunity to view the defendant ( Neil v. Biggers, 409 U.S. 188), but also had a prior familiarity with him ( see, People v. Thomas, 188 A.D.2d 569; see also, People v. Tas, 51 N.Y.2d 915).

The defendant, who suffered a gunshot wound to the thumb in the course of the crime, contends that the trial court erred in permitting the People to present evidence obtained by the polymerase-chain-reaction method (hereinafter PCR method) of DNA profiling. The test matched the defendant's blood with blood samples taken from the getaway car owned by "G", with a 1 in 2,234 probability of a random match. At the time of trial, evidence obtained through the restriction-fragment-length-polymorphism method (hereinafter RFLP method) of DNA profiling had been found to be admissible in New York ( see, People v. Wesley, 83 N.Y.2d 417). However, the newer PCR method had not yet been the subject of an appellate decision in this State. The trial court therefore conducted a hearing pursuant to Frye v. United States (293 F 1013). We agree with the court that the hearing evidence sufficiently established that the reliability of the PCR method had gained general acceptance in the relevant scientific community so as to permit the submission of evidence obtained by that method to a jury ( see, People v. Palumbo, 162 Misc.2d 650).

At the Frye hearing the People presented testimony from three highly qualified experts in the field of DNA testing, namely Dr. David Bing, Scientific Director of the Center for Blood Research Laboratories (hereinafter CBR Labs), which is affiliated with the Harvard Medical School where Bing is a member of the Department of Medicine; Dr. Robert Shaler, the Director of Forensic Biology for the Office of the Chief Medical Examiner for New York City; and Dr. Kenneth Kidd, a full professor at the Yale University School of Medicine's Department of Genetics. Their testimony established that the PCR method had been validated by numerous peer-reviewed articles in the scientific literature, was used in an increasing number of forensic laboratories throughout the United States and the world, and was widely accepted within the scientific community as reliable for forensic applications. The People also demonstrated that the PCR method was better suited than the RFLP method for forensic use since it was capable of testing smaller and degraded samples, usually the only type available at a crime scene.

CBR Labs performed the testing in this case using the HLA-DQ Alpha and the newer Amplitype PM or Polymarker variants of the PCR method. The hearing testimony showed that the two tests are based on the same scientific principles and have nearly identical methodologies and protocols, but use different primers and probes because they target different genetic loci. The HLA-DQ Alpha test targets one genetic locus while the Polymarker test targets six loci. Thus, any validation studies regarding the HLA-DQ Alpha test were applicable as well to the Polymarker test. Furthermore, Dr. Bing explained that the lack of published, peer-reviewed articles validating the Polymarker test in particular was due to the lengthy peer-review process and not to any discord in the scientific community as to its validity. Moreover, Polymarker testing had been validated by internal studies at CBR Labs and many of the other 25 individual labs known by Dr. Bing to be using that method.

Accordingly, we reject the defendant's argument that the Polymarker variant of the PCR method was too new and untested to be considered reliable. While the defendant's expert expressed that opinion at the hearing, he also testified that he had never used the Polymarker test kit, was unaware of any particular problems with it, and knew of no studies supporting his view. In any event, Frye requires only general, not unanimous, acceptance by the scientific community ( see, People v Middleton, 54 N.Y.2d 42).

We note, in addition, that there has been an overwhelming acceptance of PCR methodology in other States, many of which apply the Frye standard of reliability ( see, People v Amundson, 48 Cal.App.4th 788, 41 Cal.Rptr.2d 127; Harmon v State, 908 P.2d 434 [Alaska]; State v. Johnson, 183 Ariz. 623, 905 P.2d 1002; State v. Hill, 257 Kan. 774, 895 P.2d 1238; State v Gentry, 125 Wn.2d 570, 888 P.2d 1105; People v. Lee, 212 Mich. App. 228,

537 N.W.2d 233; Seritt v. State, 647 So.2d 1 [Ala]; State v Spencer, 663 So.2d 271 [La]; see also, State v. Begley, 1996 WL 12152 [Tenn Ct of Crim Appeals, Jan. 11, 1996]; State v Williams, 252 N.J. Super. 369, 599 A.2d 960; Redding v. State, 464 S.E.2d 824 [Ga]; Campbell v. State, 910 S.W.2d 475 [Tex]; Spencer v Commonwealth, 240 Va. 78, 393 S.E.2d 609).

The defendant also seeks reversal based on Detective Woulfe's rebuttal testimony that he arrested the defendant after the complainant identified him as the shooter. While this testimony improperly bolstered the complainant's in-court identification in violation of People v. Trowbridge ( 305 N.Y. 471), the error was harmless in light of the overwhelming evidence of the defendant's guilt ( see, People v. Johnson, 57 N.Y.2d 969; People v. Staley, 182 A.D.2d 846).

The defendant's remaining contentions are without merit. Rosenblatt, J.P., Miller, Pizzuto and Goldstein, JJ., concur.


Summaries of

People v. Morales

Appellate Division of the Supreme Court of New York, Second Department
May 28, 1996
227 A.D.2d 648 (N.Y. App. Div. 1996)

holding that PCR method had gained general acceptance under Frye

Summary of this case from People v. Shreck

allowing DQA and Polymarker tests under Frye

Summary of this case from U.S. v. Lowe

validating DQA1 and PM testing

Summary of this case from Commonwealth v. Vao Sok

In Morales, the State used a new method of DNA profiling to match defendant's blood with blood samples taken from a getaway car used in the commission of a murder.

Summary of this case from Hassett v. Long Is. R.R. Co.

In Morales, the State used a new method of DNA profiling to match defendant's blood with blood samples taken from a getaway car used in the commission of a murder.

Summary of this case from Hassett v. Long Is. R.R. Co.
Case details for

People v. Morales

Case Details

Full title:THE PEOPLE OF THE STATE OF NEW YORK, Respondent, v. ROBERTO MORALES…

Court:Appellate Division of the Supreme Court of New York, Second Department

Date published: May 28, 1996

Citations

227 A.D.2d 648 (N.Y. App. Div. 1996)
643 N.Y.S.2d 217

Citing Cases

State v. Harvey

Before the Rule 104 hearing, however, a New York court had admitted polymarker evidence. People v. Morales,N…

People, v. Owens

Defendant does not dispute the general acceptance by the scientific community of Amplitype PM (Polymarker)…